Cleared Traditional

K121074 - SCENIUM 2.0

K121074 is an FDA 510(k) clearance for SCENIUM 2.0, manufactured by Siemens Medical Solutions USA, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K121074 · Siemens Medical Solutions USA, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2012
Decision
60d
Days
Class 2
Risk

K121074 is an FDA 510(k) clearance for the SCENIUM 2.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Siemens Medical Solutions USA, Inc. (Knoxville, US). The FDA issued a Cleared decision on June 8, 2012 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Siemens Medical Solutions USA, Inc. devices

FDA 510(k) Submission Details - K121074

510(k) Number K121074 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 09, 2012
Decision Date June 08, 2012
Days to Decision 60 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 107d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1800
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K121074.
SYNGO.MR NEUROLOGY
K121459 · Siemens Medical Solutions USA, Inc. · Jun 2012
READY VIEW
K113456 · Ge Healthcare (Ge Medical Systems Scs) · Jun 2012
SYNAPSE 3D LUNG AND ABDOMEN ANALYSIS
K120648 · Fujifilm Medical System U.S.A., Inc. · Jun 2012
CENTRICITY PACS-IW
K121387 · Ge Healthcare Integrated IT Solutions · Jun 2012
SYNAPSE 3D NODULE ANALYSIS
K120679 · Fujifilm Medical Systems U.S.A, Inc. · Jun 2012
SPECTRUM V.0
K121023 · Intrinsic Medical Imaging · May 2012